Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

Clinical trial NCT03805477 · RECRUITING

Trial details

NCT number: NCT03805477
Sponsor: University Hospital, Basel, Switzerland
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)

Start date: 2019-03-20
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.